BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 32012407)

  • 1. Establishment of epigenetic markers to predict irradiation efficacy against oropharyngeal cancer.
    Kurokawa T; Nakagawa T; Matsusaka K; Fukuyo M; Mima M; Misawa K; Rahmutulla B; Ikeda JI; Hanazawa T; Okamoto Y; Kaneda A
    Cancer Sci; 2020 Apr; 111(4):1407-1416. PubMed ID: 32012407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery and development of differentially methylated regions in human papillomavirus-related oropharyngeal squamous cell carcinoma.
    Ren S; Gaykalova D; Wang J; Guo T; Danilova L; Favorov A; Fertig E; Bishop J; Khan Z; Flam E; Wysocki PT; DeJong P; Ando M; Liu C; Sakai A; Fukusumi T; Haft S; Sadat S; Califano JA
    Int J Cancer; 2018 Nov; 143(10):2425-2436. PubMed ID: 30070359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stratification of HPV-associated and HPV-negative oropharyngeal squamous cell carcinomas based on DNA methylation epigenotypes.
    Nakagawa T; Matsusaka K; Misawa K; Ota S; Fukuyo M; Rahmutulla B; Kunii N; Sakurai D; Hanazawa T; Matsubara H; Okamoto Y; Kaneda A
    Int J Cancer; 2020 May; 146(9):2460-2474. PubMed ID: 31997344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequent promoter hypermethylation associated with human papillomavirus infection in pharyngeal cancer.
    Nakagawa T; Matsusaka K; Misawa K; Ota S; Takane K; Fukuyo M; Rahmutulla B; Shinohara KI; Kunii N; Sakurai D; Hanazawa T; Matsubara H; Nakatani Y; Okamoto Y; Kaneda A
    Cancer Lett; 2017 Oct; 407():21-31. PubMed ID: 28823962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic differences between human papillomavirus-positive and -negative oropharyngeal squamous cell carcinomas.
    Biron VL; Mohamed A; Hendzel MJ; Alan Underhill D; Seikaly H
    J Otolaryngol Head Neck Surg; 2012 Apr; 41 Suppl 1():S65-70. PubMed ID: 22569052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.
    Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y
    Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Novel Functional Splice Variant of
    Guo T; Sakai A; Afsari B; Considine M; Danilova L; Favorov AV; Yegnasubramanian S; Kelley DZ; Flam E; Ha PK; Khan Z; Wheelan SJ; Gutkind JS; Fertig EJ; Gaykalova DA; Califano J
    Cancer Res; 2017 Oct; 77(19):5248-5258. PubMed ID: 28733453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic pathogenesis of human papillomavirus in upper aerodigestive tract cancers.
    Talukdar FR; Ghosh SK; Laskar RS; Kannan R; Choudhury B; Bhowmik A
    Mol Carcinog; 2015 Nov; 54(11):1387-96. PubMed ID: 25213493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization and radiosensitivity of HPV-related oropharyngeal squamous cell carcinoma patient-derived xenografts.
    Lilja-Fischer JK; Ulhøi BP; Alsner J; Stougaard M; Thomsen MS; Busk M; Lassen P; Steiniche T; Nielsen VE; Overgaard J
    Acta Oncol; 2019 Oct; 58(10):1489-1494. PubMed ID: 31510843
    [No Abstract]   [Full Text] [Related]  

  • 10. Radiotherapy alone as a possible de-intensified treatment for human papillomavirus-related locally advanced oropharyngeal squamous cell carcinoma.
    Yamamoto Y; Takemoto N; Michiba T; Seo Y; Isohashi F; Otani K; Suzuki M; Fujii T; Yoshii T; Mitani K; Yasui T; Cho H; Tomita Y; Morii E; Teshima T; Ogawa K; Inohara H
    Int J Clin Oncol; 2019 Jun; 24(6):640-648. PubMed ID: 30694402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic changes in the CDKN2A locus are associated with differential expression of P16INK4A and P14ARF in HPV-positive oropharyngeal squamous cell carcinoma.
    Schlecht NF; Ben-Dayan M; Anayannis N; Lleras RA; Thomas C; Wang Y; Smith RV; Burk RD; Harris TM; Childs G; Ow TJ; Prystowsky MB; Belbin TJ
    Cancer Med; 2015 Mar; 4(3):342-53. PubMed ID: 25619363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting Viral DNA and Promoter Hypermethylation in Salivary Rinses for Recurrent HPV-Positive Oropharyngeal Cancer.
    Shen S; Saito Y; Ren S; Liu C; Guo T; Qualliotine J; Khan Z; Sadat S; Califano JA
    Otolaryngol Head Neck Surg; 2020 Apr; 162(4):512-519. PubMed ID: 32041482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylation of HPV 16 and EPB41L3 in oral gargles: Associations with oropharyngeal cancer detection and tumor characteristics.
    Giuliano AR; Nedjai B; Lorincz AT; Schell MJ; Rahman S; Banwait R; Boulware D; Sirak B; Martin-Gomez L; Abrahamsen M; Isaacs-Soriano KA; Wenig B; Chung CH; Caudell J
    Int J Cancer; 2020 Feb; 146(4):1018-1030. PubMed ID: 31304592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Common fragile sites (CFS) and extremely large CFS genes are targets for human papillomavirus integrations and chromosome rearrangements in oropharyngeal squamous cell carcinoma.
    Gao G; Johnson SH; Vasmatzis G; Pauley CE; Tombers NM; Kasperbauer JL; Smith DI
    Genes Chromosomes Cancer; 2017 Jan; 56(1):59-74. PubMed ID: 27636103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of HPV16 African variants and quantitative analysis of viral DNA methylation in oropharyngeal squamous cell carcinomas.
    Barbieri D; Nebiaj A; Strammiello R; Agosti R; Sciascia S; Gallinella G; Landini MP; Caliceti U; Venturoli S
    J Clin Virol; 2014 Jul; 60(3):243-9. PubMed ID: 24845262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of novel methylation markers in HPV-associated oropharyngeal cancer: genome-wide discovery, tissue verification and validation testing in ctDNA.
    Misawa K; Imai A; Matsui H; Kanai A; Misawa Y; Mochizuki D; Mima M; Yamada S; Kurokawa T; Nakagawa T; Mineta H
    Oncogene; 2020 Jun; 39(24):4741-4755. PubMed ID: 32415241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HPV16 increases the number of migratory cancer stem cells and modulates their miRNA expression profile in oropharyngeal cancer.
    Hufbauer M; Maltseva M; Meinrath J; Lechner A; Beutner D; Huebbers CU; Akgül B
    Int J Cancer; 2018 Sep; 143(6):1426-1439. PubMed ID: 29663357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylation status of HPV16 E2-binding sites classifies subtypes of HPV-associated oropharyngeal cancers.
    Reuschenbach M; Huebbers CU; Prigge ES; Bermejo JL; Kalteis MS; Preuss SF; Seuthe IM; Kolligs J; Speel EJ; Olthof N; Kremer B; Wagner S; Klussmann JP; Vinokurova S; von Knebel Doeberitz M
    Cancer; 2015 Jun; 121(12):1966-76. PubMed ID: 25731880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropeptide receptor genes GHSR and NMUR1 are candidate epigenetic biomarkers and predictors for surgically treated patients with oropharyngeal cancer.
    Misawa K; Mima M; Satoshi Y; Misawa Y; Imai A; Mochizuki D; Nakagawa T; Kurokawa T; Oguro M; Ishikawa R; Yamaguchi Y; Endo S; Kawasaki H; Kanazawa T; Mineta H
    Sci Rep; 2020 Jan; 10(1):1007. PubMed ID: 31974445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TRH site-specific methylation in oral and oropharyngeal squamous cell carcinoma.
    Puttipanyalears C; Arayataweegool A; Chalertpet K; Rattanachayoto P; Mahattanasakul P; Tangjaturonsasme N; Kerekhanjanarong V; Mutirangura A; Kitkumthorn N
    BMC Cancer; 2018 Aug; 18(1):786. PubMed ID: 30081853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.